News | September 24, 2021
Novavax and Serum seek WHO approval for Covid-19 vaccine
It is a recombinant nanoparticle protein-based vaccine
It is a recombinant nanoparticle protein-based vaccine
These modules will act as a guide to doctors and health care workers to deal with post-Covid-19 issues
Emergency Use Authorisation (EUA) is granted for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
In participants 5 to 11 years of age, the vaccine was safe, well-tolerated and showed robust neutralising antibody responses. Results in children under 5 years of age are expected as soon as later this year
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
_256_384.jpg)
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
The clinical trial, to be conducted in two phases, will evaluate the safety and efficacy of Mesocel for the treatment of patients with moderate to severe Covid-19
Study to explore heterologous regimen of COVID-19 vaccines from different manufacturers in adolescents 12-16 years of age
In the final analysis of Phase 3 COVE study data, SPIKEVAX showed 93% efficacy, with the efficacy remaining durable through six months after the administration of the second dose
Subscribe To Our Newsletter & Stay Updated
